Application of telephone follow-up on the initial use of insulin glargine in patients with extended care
10.3760/cma.j.issn.1674-2907.2015.36.014
- VernacularTitle:电话随访在初始使用甘精胰岛素患者延续护理中的应用
- Author:
Junxiang GAO
1
;
Shuo KANG
;
Lijuan WANG
;
Lihui ZHANG
;
Limei GUO
;
Xing ZHANG
;
Yixuan WANG
Author Information
1. 050000 石家庄，河北医科大学第二医院内分泌科
- Keywords:
Diabetes mellitus;
Insulin monitoring;
Telephone follow-up;
Insulin;
Extended care
- From:
Chinese Journal of Modern Nursing
2015;(36):4385-4387
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effects of the telephone follow-up on blood glucose and treatment compliance among patients with the initial use of insulin glargine. Methods A total of 100 inpatients with the initial use of insulin glargine were randomly assigned to a control group and an observation group according to the random number table method, with 50 cases each. The patients of control group received routine discharge guidance, while the patients of observation group received 5 times telephone follow-up leading by doctors and nurses in three months. Patients in both groups were followed up 3 months, and their fasting blood glucose, glycated hemoglobin ( HbA1c), and treatment compliance were measured before and 3 months after the intervention. Results There was no statistically significant difference in fasting blood glucose and values of HbA1c between two groups before the intervention (P >0. 05). The fasting blood glucose in the observation group was lower than that of the control group after 3 months intervention, and the Values of HbA1c in the observation group was lower than that of the control group after intervention (P<0. 05); the behavior of diet, blood glucose monitoring, insulin treatment compliance in the observation group better than those in the control group (P<0. 05). The Compliance of exercise behavior in the observation group had no significant difference with that of the control group ( P > 0. 05 ). Conclusions Telephone follow-up can improve patient′s compliance, which is favorable for glycemic control after discharge in patients with the initial use insulin glargine.
